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a b s t r a c t
The novel dataset presented here represents the results of the
changing pattern of DNA methylation profiles in HeLa cells
exposed to chronic low dose (0.5 mM) sodium arsenite, resulting in
epithelial-to-mesenchymal transition, as well as DNA methylation
patterns in cells where inorganic arsenic has been removed.
Inorganic arsenic is a known carcinogen, though not mutagenic.
Several mechanisms have been proposed as to how inorganic
arsenic drives carcinogenesis such as regulation of the cell's redox
potential and/or epigenetics. In fact, there are gene specific studies
and limited genome-wide studies that have implicated epigenetic
factors such as DNA methylation in inorganic arsenic-mediated
epithelial-to-mesenchymal transition (EMT). However, genome-
wide studies about the impact of 1) chronic, low-dose inorganic
arsenic exposure on DNA methylation patterns during inorganic
arsenic-induced epithelial-to-mesenchymal transition, and 2) the
removal inorganic arsenic (reversal) on DNA methylation patterns,
is lacking. For this dataset, two replicates were performed with
each of the samples – non-treated, inorganic arsenic-treated, and
reverse-treated cells. We provide normalized and processed data,
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and log2 fold change in DNA methylation. The raw microarray data
are available through NCBI GEO, accession number GSE95232 and
a related research paper has been accepted for published in Tox-
icology and Applied Pharmacology (Eckstein et al., 2017) [1].
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Specifications Table
Subject area Biology
More specific sub-
ject area
Epigenetics and Toxicology
Type of data Text, raw data files
How data was
acquired
Infinium Methylation EPIC Bead Chip Methylation Array
Data format Raw, filtered
Experimental
factors
HeLa cells were exposed to 0.5 mM sodium arsenite, mimicking the levels of
arsenic in the water supply of Eastern Kentucky (in particular). Cells that had
undergone the epithelial-to-mesenchymal transition from inorganic arsenic
exposure then had the sodium arsenite removed and continued to be grown to
see if the removal of the environmental toxicant could reverse some of the
methylation and gene expression changes observed. Non-treated HeLa cells were
used as a control to which DNA methylation changes could be compared.
Experimental
features
We analyzed DNA methylation changes genome-wide by profiling HeLa cells
that were exposed to 0.5 mM sodium arsenite, as well as cells that were treated
and had arsenic removed using the methylation array.
Data accessibility Microarray data has been deposited into the NCBI GEO database (Accession
number GSE95232)
Value of the data
 Genome-wide assessment of DNA methylation changes in inorganic arsenic-mediated epithelia-to-
mesenchymal transition cells and reversal of inorganic arsenic-treated cells.
 DNA methylation profiling in cells in response to chronic, low dose inorganic arsenic exposure.
 Implication of DNA methylation as an epigenetic contributor to inorganic-arsenic mediated
epithelial-to-mesenchymal transition.
 Valuable for understanding genome-wide epigenetic implications of chronic, low dose exposure to
inorganic arsenic, a common environmental toxicant.
1. Data
The Infinium Methylation EPIC BeadChip Array profile data are provided as MINiML and TXT files
deposited into NCBI GEO, accession number GSE95232. Genomic DNA was extracted from non-treated,
inorganic arsenic-treated, and inorganic arsenic reverse-treated HeLa cells, bisulfite converted, and
applied to the BeadChip Array. Two replicates of each sample were performed. The BeadChip Array
detected DNA methylation status genome wide of non-treated, inorganic arsenic-treated, and inorganic
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arsenic reverse-treated HeLa cells. Gene ontology analysis of the differentially methylated genes revealed
that many of the genes had oncogenic signatures according to the Gene Set Enrichment Analysis
(Supplemental Tables 1–3). Specifically, many of them are connected to KRAS signaling in several types
of cancer in epithelial cells such as those of the lung, breast, and kidney tissues. A more complete
description of this data can be found in Eckstein et al. (2017) [1].
2. Experimental design, materials and methods
2.1. HeLa cell growth conditions and treatment
HeLa cells were grown as previously described in [3,4]. Reverse-treated cells were treated with
0.5 mM sodium arsenite for 36 days, at which point they were treated with water instead of sodium
arsenite (reverse-reated cells). These reverse-treated cells were harvested 10 days after reversal of
treatment.
2.2. Infinium MethylationEPIC Bead Chip – methylation array analysis
Sample preparation. Genomic DNA from non-treated, treated, and reverse treated cells was
extracted using the Qiagen DNeasy Blood and Tissue kit. DNA was initially bisulfite converted using
the Zymo EZ-96DNA Methylation Kit (Catalog #D5004) Deep-Well Format. DNA was treated with
sodium bisulfilte causing unmethlylated cytosines to convert to uracil while keeping methylated
cytosines unchanged. Then 4ul (equivalent to 750 ng DNA) of the bisulfite converted DNAwas used as
input for the Illumina Infinium HD Methylation Array. During this process, the bisulfite converted
DNA samples were denatured, neutralized, and prepared for amplification. After amplification, the
amplified DNA was enzymatically fragmented and precipitated. The resuspended DNA samples were
then dispensed onto Illumina's InfiniumMethylationEPIC BeadChip, where they underwent a series of
washing, extension, and staining procedures. The BeadChips are then coated for protection and
scanned on the Illumina HiScanHQ. Once scanning is completed, the data is uploaded into Geno-
meStudio for preliminary analysis and QC.
2.3. Data analyses
For statistical analysis, beta values were calculated. The methylation levels of CpGs were described as
beta values (0–1) representing the calculated level of methylation (0–100%). We had two technical and
two biological replicates processed by chip technique. The Pearson correlation coefficients (PCCs) were
40.99 for all the replicates, confirming a good level of reproducibility for the chip process and indi-
cating that the observed differential methylation between the cells (treatments) represented true
biological differences. Functional normalization was performed using home scripts ‘Minfi pre-
processFunNorm’ which does the background normalization. Additionally, the dye correction was
performed using noob. All CpG sites with detection value40.05, CpG sites with SNPs, as well as probes
predicted to hybridize to more than one genomic location [2] were removed.
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